Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24778030)

1.

Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.

Romain CV, Paul P, Lee S, Qiao J, Chung DH.

Anticancer Res. 2014 May;34(5):2269-74.

2.

Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma.

Romain C, Paul P, Kim KW, Lee S, Qiao J, Chung DH.

J Pediatr Surg. 2014 Jan;49(1):159-65. doi: 10.1016/j.jpedsurg.2013.09.051. Epub 2013 Oct 5.

3.

Targeting Aurora kinase A suppresses the growth of human oral squamous cell carcinoma cells in vitro and in vivo.

Tanaka H, Nakashiro K, Iwamoto K, Tokuzen N, Fujita Y, Shirakawa R, Oka R, Goda H, Hamakawa H.

Oral Oncol. 2013 Jun;49(6):551-9. doi: 10.1016/j.oraloncology.2013.02.002. Epub 2013 Mar 6.

PMID:
23481312
4.

Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia.

Katsha A, Soutto M, Sehdev V, Peng D, Washington MK, Piazuelo MB, Tantawy MN, Manning HC, Lu P, Shyr Y, Ecsedy J, Belkhiri A, El-Rifai W.

Gastroenterology. 2013 Dec;145(6):1312-22.e1-8. doi: 10.1053/j.gastro.2013.08.050. Epub 2013 Aug 29.

5.

Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2/M cell cycle arrest.

Jiang Z, Jiang J, Yang H, Ge Z, Wang Q, Zhang L, Wu C, Wang J.

Oncol Rep. 2014 Mar;31(3):1249-54. doi: 10.3892/or.2014.2986. Epub 2014 Jan 20.

PMID:
24452445
6.

Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.

Do TV, Xiao F, Bickel LE, Klein-Szanto AJ, Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, Litwin S, Golemis EA, Schilder RJ, Godwin AK, Connolly DC.

Oncogene. 2014 Jan 30;33(5):539-49. doi: 10.1038/onc.2012.632. Epub 2013 Jan 21.

7.

HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.

Fanale D, Bazan V, Corsini LR, Caruso S, Insalaco L, Castiglia M, Cicero G, Bronte G, Russo A.

Breast Cancer Res Treat. 2013 Aug;140(3):505-17. doi: 10.1007/s10549-013-2649-0. Epub 2013 Aug 8.

PMID:
23925655
8.

Effects of stable knockdown of Aurora kinase A on proliferation, migration, chromosomal instability, and expression of focal adhesion kinase and matrix metalloproteinase-2 in HEp-2 cells.

Zhang H, Chen X, Liu B, Zhou L.

Mol Cell Biochem. 2011 Nov;357(1-2):95-106. doi: 10.1007/s11010-011-0879-1. Epub 2011 May 18.

PMID:
21590355
9.

The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.

Sehdev V, Peng D, Soutto M, Washington MK, Revetta F, Ecsedy J, Zaika A, Rau TT, Schneider-Stock R, Belkhiri A, El-Rifai W.

Mol Cancer Ther. 2012 Mar;11(3):763-74. doi: 10.1158/1535-7163.MCT-11-0623. Epub 2012 Feb 1.

10.

FAK is a critical regulator of neuroblastoma liver metastasis.

Lee S, Qiao J, Paul P, O'Connor KL, Evers MB, Chung DH.

Oncotarget. 2012 Dec;3(12):1576-87.

11.

Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.

Lu Y, Liu Y, Jiang J, Xi Z, Zhong N, Shi S, Wang J, Wei X.

Oncol Rep. 2014 Jul;32(1):243-9. doi: 10.3892/or.2014.3194. Epub 2014 May 16.

PMID:
24841948
12.

Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.

Mohan P, Castellsague J, Jiang J, Allen K, Chen H, Nemirovsky O, Spyra M, Hu K, Kluwe L, Pujana MA, Villanueva A, Mautner VF, Keats JJ, Dunn SE, Lazaro C, Maxwell CA.

Oncotarget. 2013 Jan;4(1):80-93.

13.
14.

Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.

Park HS, Park WS, Bondaruk J, Tanaka N, Katayama H, Lee S, Spiess PE, Steinberg JR, Wang Z, Katz RL, Dinney C, Elias KJ, Lotan Y, Naeem RC, Baggerly K, Sen S, Grossman HB, Czerniak B.

J Natl Cancer Inst. 2008 Oct 1;100(19):1401-11. doi: 10.1093/jnci/djn304. Epub 2008 Sep 23. Erratum in: J Natl Cancer Inst. 2008 Dec 3;100(23):1740.

15.

PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.

Crosswell HE, Dasgupta A, Alvarado CS, Watt T, Christensen JG, De P, Durden DL, Findley HW.

BMC Cancer. 2009 Nov 25;9:411. doi: 10.1186/1471-2407-9-411.

16.

Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.

Xu LF, Ni JY, Sun HL, Chen YT, Wu YD.

World J Gastroenterol. 2013 Mar 21;19(11):1749-59. doi: 10.3748/wjg.v19.i11.1749.

17.

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.

den Hollander J, Rimpi S, Doherty JR, Rudelius M, Buck A, Hoellein A, Kremer M, Graf N, Scheerer M, Hall MA, Goga A, von Bubnoff N, Duyster J, Peschel C, Cleveland JL, Nilsson JA, Keller U.

Blood. 2010 Sep 2;116(9):1498-505. doi: 10.1182/blood-2009-11-251074. Epub 2010 Jun 2.

18.

β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.

Dere R, Perkins AL, Bawa-Khalfe T, Jonasch D, Walker CL.

J Am Soc Nephrol. 2015 Mar;26(3):553-64. doi: 10.1681/ASN.2013090984. Epub 2014 Oct 13.

PMID:
25313256
19.

Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells.

Horwacik I, Durbas M, Boratyn E, Węgrzyn P, Rokita H.

Cancer Lett. 2013 Dec 1;341(2):248-64. doi: 10.1016/j.canlet.2013.08.018. Epub 2013 Aug 17.

PMID:
23962557
20.

CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express Aurora kinase A.

Yang J, Ikezoe T, Nishioka C, Nobumoto A, Udaka K, Yokoyama A.

Int J Cancer. 2013 Dec 1;133(11):2706-19. doi: 10.1002/ijc.28277. Epub 2013 Jun 10.

PMID:
23686525
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk